NCT05283967 (PEE-TB) is a clinical trial of urine colorimetric assay in Tuberculosis, sponsored by University of Virginia.

Who is sponsoring NCT05283967?

NCT05283967 is sponsored by University of Virginia.

What drugs are being tested in NCT05283967?

Interventions in NCT05283967: urine colorimetric assay.

What condition does NCT05283967 study?

NCT05283967 studies Tuberculosis.

Is NCT05283967 still recruiting?

NCT05283967 is currently completed. Last updated 8 May 2024.

Last reviewed 2024-05-08 · How we verify

NCT05283967: PEE-TB

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Urine Colorimetry for Tuberculosis Pharmacokinetics Evaluation in Children and Adults

Completed Last updated 8 May 2024

What this trial tests

trial testing urine colorimetric assay in Tuberculosis in 150 participants. Completed in 1 December 2023.

Timeline

1 January 2019

Primary endpoint
30 December 2022

1 December 2023

Quick facts

Lead sponsor	University of Virginia
Status	Completed
Study type	OBSERVATIONAL
Enrollment	150
Start date	1 January 2019
Primary completion	30 December 2022
Estimated completion	1 December 2023
Sites	2 locations across United States

Drugs / interventions tested

urine colorimetric assay

Conditions studied

Tuberculosis — all drugs for Tuberculosis →

Sponsor

University of Virginia

Who can join

4 and older, any sex, with Tuberculosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of the study is to generate receiver-operating-characteristic (ROC) curves for urine colorimetry to identify tuberculosis (TB) patients (children and adults) with low drug anti-TB drug exposures, which will define the diagnostic accuracy. The central hypothesis is that urine colorimetry will successfully identify patients with low anti-TB serum drug levels, and do so with diagnostic characteristics similar to other widely used tests in TB management.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Roadblocks and resilience: A qualitative study of the impact of pediatric tuberculosis on Tanzanian households and solutions from caregivers.
Petros de Guex K, Augustino D, Mejan P, Gadiye R, et al · · 2023 · cited 6× · PMID 37021699 · DOI 10.1080/17441692.2023.2196569
Duration of Symptoms Prior to Pediatric and Adolescent Tuberculosis Diagnosis and Its Impact on Schooling in Tanzania: A Mixed Methods Study.
Ilaiwy G, Lukumay S, Augustino D, Mejan P, et al · · 2023 · cited 1× · PMID 37094782 · DOI 10.4269/ajtmh.22-0798

Verify or expand the search:

Other recruiting trials for Tuberculosis

Currently open trials in the same condition.

NCT05917210 — Peer-led Implementation of TB-HIV Education and Adherence Counseling in Uganda · NA · recruiting
NCT07170735 — Quantitative Measurement of Plasma and Urine MTB Cell-free DNA Level · recruiting
NCT07484490 — Effects of the Active Cycle of Breathing Technique With and Without Balloon Blowing Therapy in Tuberculosis · NA · recruiting
NCT06318416 — Precision Rifampin Trial for Personalized Dosing · Phase 1 · recruiting
NCT07170800 — A Phase 2b Clinical Study of JDB0131 Benzenesulfonate Tablets · Phase 2 · recruiting

Other University of Virginia trials

Trials by the same sponsor.

NCT05880355 — Multimodality Cardiovascular Imaging for the Translation of Therapies for Vascular Activation After MI · EARLY_PHASE1 · not yet recruiting
NCT07405645 — Stereotactic MRI-guided Focused Ultrasound Mesencephalotomy · NA · recruiting
NCT07146685 — Effect of Local Anesthetic Concentration on Rebound Pain: A Randomized Control Study · Phase 4 · not yet recruiting
NCT07298941 — Resilience Enhancement Following Sleep Treatment · Phase 2 · recruiting
NCT07036315 — Meaning in Music-Based Pain Modulation · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05283967 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Virginia
Last refreshed: 8 May 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05283967.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing